Sort   by:  
 Page size 
GenomicsSPIB and BATF provide alternate determinants of IRF4 occupancy in Diffuse Large B-cell Lymphoma linked to disease heterogeneity
ChIP-seq data for the transcription factors (TFs) IRF4, PU.1 and SPIB from the cell lines OCI-LY3, OCI-LY10 and H929, and BATF from the cell lines OCI-Ly3 and OCI-Ly10. In addition ChIP-seq for the TFs IRF4, PU.1 and SPIB from the cell line OCI-LY3 following transfections of scramble/SPIB-siRNA. ChI...
ORGANISM(S): Homo sapiens 
2014-06-03 | E-GEOD-56857 | biostudies-arrayexpress
UnknownNon-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium.
Not available
S-EPMC3928289 | biostudies-literature
UnknownDo patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.
Not available
S-EPMC9385759 | biostudies-literature
UnknownData monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register.
Not available
S-EPMC10264214 | biostudies-literature
UnknownUncoupling FoxO3A mitochondrial and nuclear functions in cancer cells undergoing metabolic stress and chemotherapy.
Not available
S-EPMC5833443 | biostudies-literature
UnknownProgression independent of relapse activity in relapsing multiple sclerosis: impact and relationship with secondary progression.
Not available
S-EPMC11319422 | biostudies-literature
UnknownThe Italian multiple sclerosis register.
Not available
S-EPMC6329744 | biostudies-literature
UnknownAutoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium.
Not available
S-EPMC2288717 | biostudies-literature
UnknownRationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes Project.
Not available
S-EPMC4155460 | biostudies-literature
UnknownDistinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Not available
S-EPMC7027476 | biostudies-literature
Sort   by:  
 Page size